|
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa |
1UG1EY033286-01 |
|
NEI |
2022 |
|
Computing Core |
5P30EY001319-48 |
|
NEI |
2022 |
|
Virtual prototyping for retinal prosthesis patients |
5R00EY029329-05 |
|
NEI |
2022 |
|
Computing Luminance and Contrast in Prosthetically Driven Retina |
5R01EY029259-05 |
|
NEI |
2022 |
|
Automated Orientation & Mobility Training in Virtual Reality for Low Vision Rehabilitation |
5R01EY030470-04 |
|
NEI |
2022 |
|
Short Term Training in Health Professional Schools |
5T35EY007088-37 |
|
NEI |
2022 |
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center |
5UG1EY023204-09 |
|
NEI |
2022 |
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Data Coordinating Center |
5UG1EY023206-09 |
|
NEI |
2022 |
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control |
5UG1EY023208-09 |
|
NEI |
2022 |
|
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center |
5UG1EY023210-09 |
|
NEI |
2022 |